Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health

Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health Diana M. Zuckerman PhD Affiliation Diana M. Zuckerman is president of the National Center for Health Research, Washington, DC.CopyRightCorrespondence should be sent to Diana M. Zuckerman, 1001 Connecticut Ave, NW, Suite 1100, Washington, DC 20036 (e-mail: dz@center4research.org). Reprints can be ordered at http://www.ajph.org by clicking the "Reprints" link. https://doi.org/10.2105/AJPH.2021.306273 Accepted: March 07, 2021 Published Online: May 05, 2021